Treating Patients With Chemotherapy and Biotherapy
Monica Fradkin, RN, BSN, MPH, OCN, Oncology Nursing Education Coordinator, Yale School of Nursing, Smilow Cancer Hospital at Yale-New Haven, discusses treating patients with chemotherapy and biotherapy.
Monica Fradkin, RN, BSN, MPH, OCN, Oncology Nursing Education Coordinator, Yale School of Nursing, Smilow Cancer Hospital at Yale-New Haven, discusses treating patients with chemotherapy and biotherapy.
Clinical Pearls
Biotherapies are very targeted, Fradkin says, targeting one specific cell type or gene. All biotherapies are often grouped together as hazardous, even though they may not all be. Safety measures still need to be taken to keep patients safe.
- Biotherapy is very targeted, looking at one specific cell type or gene
- Biotherapies are categorized together as hazardous drugs, when they may not all be
- Safety measures need to be kept in place in order to keep patients safe
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
December 10th 2024In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.
Read More
